President Trump's signature legislative achievement, the Tax Cuts and Jobs Act (the "Act"), brought the most sweeping change to U.S. tax law since 1986. The Act includes many changes that may impact the way tax-exempt organizations operate. Specifically, the Act, modifies the way unrelated business income is calculated and imposes limitations on net operating losses (“NOLs”). Such changes have the potential to put tax-exempt organizations, including qualified retirement plans, at a disadvantage relative to for-profit organizations and may ultimately drive changes to the way qualified plans operate. Sponsors of qualified retirement plans and other exempt organizations should carefully review their investments to determine the potential tax and administrative burdens of these changes and whether any mitigation strategies are available.
Alvarez & Marsal's Compensation & Benefits team is available to discuss any questions that you may have to help mitigate your UBIT liability arising from these changes. Please feel free to contact us for additional information.
Navigating Global Pharma Policy
January 26, 2026
As the U.S. considers imposing tariffs on European pharmaceutical imports, the ripple effects could be felt across the global healthcare landscape. For an industry already grappling with rising R&D costs and competitive pressures, these tariffs threaten to erode profit margins and disrupt finely tuned supply chains.
The State of Transformation for U.S. Healthcare Providers
January 26, 2026
Market dynamics for health systems are shifting. The most significant driver is the federal Medicaid mandate, which expired at the end of December 2025 and is now pending legislation. This uncertainty is prompting health system leaders to rethink strategy and operations. In this context, we’ll share how other health systems are responding and what these changes mean for organizations like yours.
ALVAREZ & MARSAL GLOBAL TRANSACTION ADVISORY GROUP ANNOUNCES 15 MANAGING DIRECTOR PROMOTIONS
January 26, 2026
Alvarez & Marsal (A&M) Global Transaction Advisory Group (Global TAG) today announced the promotion of 15 professionals to Managing Director, reflecting the firm’s continued investment in client service excellence and internal talent development on a global growth path.
Alvarez & Marsal advises NIBC on an LP-led secondary transaction
January 23, 2026
A&M advised NIBC on a successful LP-led secondary transaction involving the sale of a portfolio of private equity fund interests to De Wereld van Vermaat, through its fund investment arm, M Eight.
